Clostridium Difficile Infection (CDI) - Epidemiology Forecast to 2024 - PowerPoint PPT Presentation

View by Category
About This Presentation

Clostridium Difficile Infection (CDI) - Epidemiology Forecast to 2024


Research Beam added a report on “Clostridium Difficile Infection (CDI) - Epidemiology Forecast to 2024” Enquiry about report: – PowerPoint PPT presentation

Number of Views:74


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Clostridium Difficile Infection (CDI) - Epidemiology Forecast to 2024

EpiCast Report Clostridium Difficile Infection
(CDI) - Epidemiology Forecast to 2024
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
TELEPHONE 1 (503) 894-6022 E-MAIL
Published on Oct 2014

Report Overview
  • Clostridium difficile infections (CDI) are
    primarily transmitted through the fecal-oral
    route. There are two major sources of CDI
    healthcare-associated CDI (HA-CDI) and
    community-associated CDI (CA-CDI). The typical
    clinical symptoms of CDI range from watery
    diarrhea, anorexia, and nausea, to
    hypoalbuminemia and abdominal tenderness in
    severe cases. Though suspected in all patients
    with antibiotic-associated diarrhea, the
    confirmatory diagnosis of CDI is primarily based
    on the combination of clinical features exhibited
    by the patient and the results of various
    laboratory tests including stool tests, as well
    as, in certain rare scenarios, endoscopy or
    radiologic tests. Recurrence and complications of
    CDI usually pose grave challenges for the
    treatment and management of this condition and
    occur in about 20-30 of the patients treated
    successfully for their first episode.
  • This report provides an overview of the risk
    factors, comorbidities, and the global and
    historical trends for CDI in the seven major
    markets (7MM) (US, France, Germany, Italy, Spain,
    UK, and Japan). It includes a 10-year
    epidemiological forecast for the diagnosed
    incident cases of all-CDI segmented by sex and by
    age (in five-year age groups beginning at 18
    years and ending at 85 years). The term all-CDI
    is defined as any instance of suspected CDI and
    diarrhea, with stool samples testing positive for
    toxin A, B, or both (enzyme immunoassay EIA,
    cytotoxicity test, or polymerase chain reaction
    PCR) or revealing the presence of
    toxin-producing C. difficile, and includes both
    HA-CDI and CA-CDI. The report also provides the
    10-year epidemiology forecast for the all-CDI
    cases segmented by epidemiological association
    into HA-CDI and CA-CDI. Additionally, the report
    provides a 10-year epidemiological forecast for
    the recurrent all-CDI cases with a further
    segmentation by number of recurrences.
  • Read More At http//


Table of Content
1 Table of Contents 4 1.1 List of Tables 6 1.2
List of Figures 7 2 Introduction 8 2.1 Catalyst
8 2.2 Related Reports 9 3 Epidemiology 10 3.1
Disease Background 10 3.2 Risk Factors and
Comorbidities 11 4 Appendix 48 4.1 Bibliography
48 4.2 About the Authors 55 Enquire At

Similar Market Studies
Toothbrushes Replacement Heads Market in China
to 2017 The report presents detailed data on
consumption trends in the Toothbrushes
Replacement Heads category in China, analyzing
consumption volumes and values at segment level.
It also provides indispensable data on
distribution channels along with latest industry
news and mergers acquisitions (of Oral Hygiene
market).This product is part of Canadeans new on
demand range. These reports are built on the
foundation of the most up-to-date data at the
moment of purchase, guaranteeing their
sensitivity to the current state of the market,
and facilitating informed business decisions that
can be made with the utmost of confidence.
acement-heads-in-china-to-2017-market Ewing
Sarcoma - Pipeline Review, H1 2015 Global Markets
Directs report features investigational drugs
from across globe covering over 20 therapy areas
and nearly 3,000 indications. The report is built
using data and information sourced from Global
Markets Directs proprietary databases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes
periodic updation following a stringent set of
processes that ensures that all the profiles are
updated with the latest set of information.
Additionally, processes including live news
deals tracking, browser based alert-box and
clinical trials registries tracking ensure that
the most recent developments are captured on a
real time basis. http//

Visit us at
Stay With Us
5933 NE Win Sivers Drive, 205, Portland, OR
97220 United States
TELEPHONE 1 (800) 910-6452 DIRECT 1 (503)
894-6022 E-MAIL